0001209191-23-045832.txt : 20230815 0001209191-23-045832.hdr.sgml : 20230815 20230815161356 ACCESSION NUMBER: 0001209191-23-045832 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230811 FILED AS OF DATE: 20230815 DATE AS OF CHANGE: 20230815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blank Jeremy CENTRAL INDEX KEY: 0001962987 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38716 FILM NUMBER: 231174978 MAIL ADDRESS: STREET 1: 6446 DREXEL AVENUE CITY: LOS ANGELES STATE: CA ZIP: 90048 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gamida Cell Ltd. CENTRAL INDEX KEY: 0001600847 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 NAHUM HAFZADI STREET CITY: JERUSALEM STATE: L3 ZIP: 95484 BUSINESS PHONE: 97226595666 MAIL ADDRESS: STREET 1: 5 NAHUM HAFZADI STREET CITY: JERUSALEM STATE: L3 ZIP: 95484 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-11 0 0001600847 Gamida Cell Ltd. GMDA 0001962987 Blank Jeremy C/O GAMIDA CELL LTD. 116 HUNTINGTON AVENUE BOSTON MA 02116 1 0 0 0 0 Ordinary Shares 2023-08-11 4 A 0 4000 0.00 A 4000 D Ordinary Shares 5169471 I By Community Master Fund, LP Share Option (Right to Buy) 1.22 2023-08-11 4 A 0 19000 0.00 A 2033-08-10 Ordinary Shares 19000 19000 D Represents a restricted share unit award, which shall vest on August 11, 2024, subject to the Reporting Person's continuous service through such vesting date. Securities are held directly by Community Master Fund, LP ("Master Fund"). Community US Fund Management, Inc. (the "Firm") is the investment manager to Master Fund and may be deemed to beneficially own these securities. The Reporting Person is the principal and portfolio manager of the Firm and exercises investment discretion with respect to these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein, if any. This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on November 11, 2023, subject to the Reporting Person's continuous service through each such vesting date. /s/ Joshua F. Patterson, Attorney-in-Fact 2023-08-15